Cargando…
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
Adenovirus vectored vaccines are a highly effective strategy to induce cellular immune responses which are particularly effective against intracellular pathogens. Recombinant simian adenovirus vectors were developed to circumvent the limitations imposed by the use of human adenoviruses due to widesp...
Autores principales: | Folegatti, Pedro M., Bellamy, Duncan, Roberts, Rachel, Powlson, Jonathan, Edwards, Nick J., Mair, Catherine F., Bowyer, Georgina, Poulton, Ian, Mitton, Celia H., Green, Nicky, Berrie, Eleanor, Lawrie, Alison M., Hill, Adrian V.S., Ewer, Katie J., Hermon-Taylor, John, Gilbert, Sarah C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630572/ https://www.ncbi.nlm.nih.gov/pubmed/31096710 http://dx.doi.org/10.3390/vaccines7020040 |
Ejemplares similares
-
CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination
por: Sharpe, Hannah R., et al.
Publicado: (2022) -
Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
por: Antrobus, Richard D, et al.
Publicado: (2014) -
Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
por: Berg, Adam, et al.
Publicado: (2021) -
Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
por: Zhang, Cheng, et al.
Publicado: (2023) -
A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial
por: Folegatti, Pedro M., et al.
Publicado: (2021)